Skip to content

Built for breakthroughs

You have the vision. You know there are risks. GATC Health is a tech-bio company leveraging proprietary AI to accelerate and de-risk the way safer and more effective drugs are discovered and developed — benefitting biopharma companies and their investors.

“GATC Health helps get safe and innovative medicine to patients sooner. Our AI rapidly and accurately predicts clinical endpoints before trial design, meaning management teams are much more effective in their drug candidate selection process.” 

Dr. Rahul Gupta

President, GATC Health

Your partner in progress

While you navigate one of the most complex and high stakes pursuits in the world – drug development – GATC Health has proven to support that work. It’s what we’re built for. 

A platform powering safer, more effective therapies.

Our purpose-built Operon™ platform simulates human biochemistry’s billions of interactions to understand the effects of exogenous compounds on healthy human biology. When you know the right questions to ask, where will the right answers lead you?

The tools to advance together

Expedite success with whole-body modeling that radically reduces the time and costs needed to validate and risk-assess, predicting biological responses with optimal speed and precision.

Biotech companies
  • 400 trillion
    genetic datapoints analyzed
  • 8 minutes
    in 8 minutes or less
  • 91 %
    specificity predictions for negative activations on biological targets
  • 86 %
    sensitivity predictions for positive activations on biological targets
Pharma companies
  • 91 %
    specificity predictions for negative activations on biological targets
  • 86 %
    sensitivity predictions for positive activations on biological targets
  • 20 x
    improvement over industry averages
  • 3-5
    candidates with the greatest potential
For investors
  • 10-12
    a year nominating drug candidates
  • 91 %
    specificity predictions for negative activations on biological targets
  • 86 %
    sensitivity predictions for positive activations on biological targets

This is mission-specific artificial intelligence, which understands complex biological systems at a molecular level. I believe GATC Health is radically transforming drug discovery and development, accelerating drug candidates that are safer, more effective and focused on restoring homeostasis.

Herb Boyer

Co-Founder of Genentech

“GATC’s AI has enabled this first-of-a-kind combination of financing protected by insurance in case the clinical trial is not successful. The early response from biotech companies and large brokerage firms for this product has exceeded our expectations which represents the pent-up demand for this innovative financing program.”

Ben Canagaretna

Global Managing Director of Acrisure Re Corporate Advisory & Solutions

The world depends on your discovery

Partner with a team who puts your science and success first. Bringing leading technologists, scientists and business minds to help drive your strategy and bring your ideas to fruition at the speed of AI.